Vas Narasimhan, Novartis CEO (Hollie Adams/Bloomberg via Getty Images)
April 10, 2025 03:40 PM EDT
Pharma
Manufacturing

No­var­tis fol­lows Lil­ly and J&J in an­nounc­ing multi­bil­lion-dol­lar US man­u­fac­tur­ing in­vest­ment

Kyle LaHucik

Senior Reporter

With US tar­iffs on phar­ma­ceu­ti­cals like­ly to come “very soon,” an­oth­er of the world’s largest drug­mak­ers is an­nounc­ing plans to beef up …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mar­ket tur­moil is tank­ing biotech M&A and IPOs. Here's the play­book star­tups will use to sur­vive

Makary wants to re­place an­i­mal test­ing with organoids. It may take a while

Re­cruiters say some bio­phar­mas pause hir­ing as they strug­gle to make sense of on­go­ing un­cer­tain­ty

Ex­clu­sive: Meri­da Bio­sciences gets $121M to treat au­toim­mune and al­ler­gy dis­eases at their roots

Phar­ma tar­iffs: Here’s what a po­ten­tial roll­out could look like

Bris­tol My­er­s' im­munother­a­py com­bo nets ap­provals in col­orec­tal and liv­er can­cer

A service from the Financial Times